高雄醫學大學圖書館 |

語系/ Language: 繁體中文

登入

回首頁

探討辨認聚乙二醇抗體於聚乙二醇修飾奈米藥物療效與藥物動力學之影響及創新奈...

謝元欽

探討辨認聚乙二醇抗體於聚乙二醇修飾奈米藥物療效與藥物動力學之影響及創新奈米藥物定量系統之研發 = Using the anti-polyethylene glycol antibody to estimate the influence of the therapeutic efficacy and pharmacokinetics of pegylated nanomedicine and to develop the novel drug quantification system

紀錄類型:	書目-語言資料,印刷品 : 單行本
並列題名:	Using the anti-polyethylene glycol antibody to estimate the influence of the therapeutic efficacy and pharmacokinetics of pegylated nanomedicine and to develop the novel drug quantification system
作者:	謝元欽
出版地:	[高雄市]
出版者:	[撰者];
出版年:	民106[2017]
面頁冊數:	108面圖 : 30公分;

探討辨認聚乙二醇抗體於聚乙二醇修飾奈米藥物療效與藥物動力學之影響及創新奈米藥物定量系統之研發 = Using the anti-polyethylene glycol antibody to estimate the influence of the therapeutic efficacy and pharmacokinetics of pegylated nanomedicine and to develop the novel drug quantification system
謝元欽

探討辨認聚乙二醇抗體於聚乙二醇修飾奈米藥物療效與藥物動力學之影響及創新奈米藥物定量系統之研發 = Using the anti-polyethylene glycol antibody to estimate the influence of the therapeutic efficacy and pharmacokinetics of pegylated nanomedicine and to develop the novel drug quantification system / 謝元欽(Yuan-Chin Hsieh)撰 - [高雄市] : [撰者], 民106[2017]. - 108面 ; 圖 ; 30公分.
含參考書目.

探討辨認聚乙二醇抗體於聚乙二醇修飾奈米藥物療效與藥物動力學之影響及創新奈米藥物定量系統之研發 = Using the anti-polyethylene glycol antibody to estimate the influence of the therapeutic efficacy and pharmacokinetics of pegylated nanomedicine and to develop the novel drug quantification system
LDR:01000nam0 2200169 450 001 306243
005 20220318102203.0
010 0 $b 平裝
100 $a 20170921y2017 000y0chiy0901 e
101 0 $a eng $d chi $d eng
102 $a tw
200 1 $a 探討辨認聚乙二醇抗體於聚乙二醇修飾奈米藥物療效與藥物動力學之影響及創新奈米藥物定量系統之研發 $d Using the anti-polyethylene glycol antibody to estimate the influence of the therapeutic efficacy and pharmacokinetics of pegylated nanomedicine and to develop the novel drug quantification system $f 謝元欽(Yuan-Chin Hsieh)撰
210 $a [高雄市] $c [撰者] $d 民106[2017]
215 0 $a 108面 $c 圖 $d 30公分
314 $a 指導教授:鄭添祿
320 $a 含參考書目
328 $a 博士論文--高雄醫學大學醫學研究所博士班
510 1 $a Using the anti-polyethylene glycol antibody to estimate the influence of the therapeutic efficacy and pharmacokinetics of pegylated nanomedicine and to develop the novel drug quantification system
700 1 $a 謝元欽 $3 480927